U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 16 results

Status:
US Approved Rx (2022)
First approved in 2022

Class (Stereo):
CHEMICAL (ACHIRAL)



PF-04965842 is an orally administered selective Janus kinase 1 (JAK1) inhibitor. PF-04965842 is currently in clinical trials for the treatment of autoimmune diseases.
Status:
US Approved Rx (2019)
First approved in 1997

Class (Stereo):
CHEMICAL (ACHIRAL)



Tazarotene a novel acetylenic retinoid is known to be effective in the topical treatment of psoriasis and acne. Tazarotene is rapidly and completely metabolized to its active metabolite tazarotenic acid. The exact mechanism of action of tazarotenic a...
Status:
US Approved Rx (2020)
First approved in 1993

Class (Stereo):
CHEMICAL (ABSOLUTE)



5E-Calcipotriol is a geometric analog of vitamin D derivative calcipotriol. It was shown to enhance anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model and anticancer activity of imatinib in an in vivo lung cancer model. The ...
Status:
US Approved Rx (2020)
First approved in 1977

Class (Stereo):
CHEMICAL (ABSOLUTE)



Desoximetasone (Topicort®) is a topical anti-inflammatory glucocorticoid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses and for the treatment of plaque psoriasis in patients 18 years o...
Status:
US Approved Rx (1977)
First approved in 1964

Class (Stereo):
CHEMICAL (ACHIRAL)



Nortriptyline is a second-generation tricyclic antidepressant (TCA) marketed as the hydrochloride salt under the trade names Sensoval, Aventyl, Pamelor, Norpress, Allegron, Noritren and Nortrilen. Nortriptyline is used in the treatment of depression ...
Status:
Investigational

Class (Stereo):
CHEMICAL (RACEMIC)



Amiselimod (MT-1303) is a selective sphingosine 1-phosphate 1 (S1P1 ) receptor modulator which is currently being developed for the treatment of various autoimmune diseases. Unlike some other S1P receptor modulators, amiselimod seemed to show a favou...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Piclidenoson (CF101), generically known as IB-MECA (methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-b-D-ribofuronamide), is an oral small molecule drug formulated in a tablet. The activity of CF101 as an anti-inflammatory agent has been tested in a number o...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



PF-06700841 is an inhibitor of JAK1 and TYK2 kinases. PF-06700841 tosylate salt is potentially a treatment of systemic lupus erythematosus and plaque psoriasis.
Status:
US Approved Rx (2019)
First approved in 1997

Class (Stereo):
CHEMICAL (ACHIRAL)



Tazarotene a novel acetylenic retinoid is known to be effective in the topical treatment of psoriasis and acne. Tazarotene is rapidly and completely metabolized to its active metabolite tazarotenic acid. The exact mechanism of action of tazarotenic a...
Status:
US Approved Rx (2020)
First approved in 1993

Class (Stereo):
CHEMICAL (ABSOLUTE)



5E-Calcipotriol is a geometric analog of vitamin D derivative calcipotriol. It was shown to enhance anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model and anticancer activity of imatinib in an in vivo lung cancer model. The ...

Showing 1 - 10 of 16 results